In December 2016 Harbour Antibodies was acquired by Harbour BioMed, a Shanghai-based company, to develop next-generation therapeutic antibodies for cancer.
| Headquarters | Cambridge, MA |
| Website | www.harbourantibodies.com |
| Partnerships | Over 30 revenue-generating partnerships to date |